News on Ligand Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated Ligand Pharmaceuticals news from BioPortfolio.com Wed, 10 Feb 2010 12:18:45 GMT en Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038960&HITNO=0&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537852243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038960&HITNO=0&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537852243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038931&HITNO=1&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038931&THISHREF=http://c.moreover.com/click/here.pl%3fz2537838958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038931&HITNO=1&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038931&THISHREF=http://c.moreover.com/click/here.pl%3fz2537838958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Ligand posts 4Q profit as charge comes off bookshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040763&HITNO=2&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040763&THISHREF=http://c.moreover.com/click/here.pl%3fz2538860090%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040763&HITNO=2&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040763&THISHREF=http://c.moreover.com/click/here.pl%3fz2538860090%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: Ligand Pharmaceuticals Cuts Loss for 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039131&HITNO=3&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039131&THISHREF=http://c.moreover.com/click/here.pl%3fz2537942477%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039131&HITNO=3&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039131&THISHREF=http://c.moreover.com/click/here.pl%3fz2537942477%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Diego Business Journal: News and FDA Updates for IMS Health (NYSE:RX), Incyte (Nasdaq:INCY), Ligand (NASDAQ:LGND)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040265&HITNO=4&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040265&THISHREF=http://c.moreover.com/click/here.pl%3fz2538680663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040265&HITNO=4&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040265&THISHREF=http://c.moreover.com/click/here.pl%3fz2538680663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Chronicle: Treatment Of Rare Type Of Bone Tumour: Promising Results With Denosumabhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040377&HITNO=5&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040377&THISHREF=http://c.moreover.com/click/here.pl%3fz2538713134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040377&HITNO=5&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040377&THISHREF=http://c.moreover.com/click/here.pl%3fz2538713134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Asperfuranone from Aspergillus nidulans Inhibits Proliferation of Human Non-Small Cell Lung Cancer A549 Cells via Blocking Cell Cycle Progression and Inducing Apoptosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040131&HITNO=6&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040131&THISHREF=http://c.moreover.com/click/here.pl%3fz2538602297%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040131&HITNO=6&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040131&THISHREF=http://c.moreover.com/click/here.pl%3fz2538602297%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBasic and Clinical Pharmacology and Toxicology: Life Sciences: Research from Seoul National University, Dental Research Institute yields new findings on life scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039726&HITNO=7&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039726&THISHREF=http://c.moreover.com/click/here.pl%3fz2538342342%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039726&HITNO=7&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039726&THISHREF=http://c.moreover.com/click/here.pl%3fz2538342342%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: D-Mab Ascending Bone Throne: Phase III Strong in Prostate, toohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=8&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=8&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035243&HITNO=9&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035243&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163912%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035243&HITNO=9&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035243&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163912%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035246&HITNO=10&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035246&THISHREF=http://c.moreover.com/click/here.pl%3fz2536164492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035246&HITNO=10&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035246&THISHREF=http://c.moreover.com/click/here.pl%3fz2536164492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036884&HITNO=11&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036884&THISHREF=http://c.moreover.com/click/here.pl%3fz2536813000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036884&HITNO=11&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036884&THISHREF=http://c.moreover.com/click/here.pl%3fz2536813000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034963&HITNO=12&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034963&THISHREF=http://c.moreover.com/click/here.pl%3fz2536070294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034963&HITNO=12&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034963&THISHREF=http://c.moreover.com/click/here.pl%3fz2536070294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034952&HITNO=13&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034952&THISHREF=http://c.moreover.com/click/here.pl%3fz2536063528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034952&HITNO=13&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034952&THISHREF=http://c.moreover.com/click/here.pl%3fz2536063528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035289&HITNO=14&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035289&THISHREF=http://c.moreover.com/click/here.pl%3fz2536185463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035289&HITNO=14&MSIZE=339&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ligand%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035289&THISHREF=http://c.moreover.com/click/here.pl%3fz2536185463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: